» Articles » PMID: 38420019

Predicting Voxel-level Dose Distributions of Single-isocenter Volumetric Modulated Arc Therapy Treatment Plan for Multiple Brain Metastases

Overview
Journal Front Oncol
Specialty Oncology
Date 2024 Feb 29
PMID 38420019
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Brain metastasis is a common, life-threatening neurological problem for patients with cancer. Single-isocenter volumetric modulated arc therapy (VMAT) has been popularly used due to its highly conformal dose and short treatment time. Accurate prediction of its dose distribution can provide a general standard for evaluating the quality of treatment plan. In this study, a deep learning model is applied to the dose prediction of a single-isocenter VMAT treatment plan for radiotherapy of multiple brain metastases.

Method: A U-net with residual networks (U-ResNet) is employed for the task of dose prediction. The deep learning model is first trained from a database consisting of hundreds of historical treatment plans. The 3D dose distribution is then predicted with the input of the CT image and contours of regions of interest (ROIs). A total of 150 single-isocenter VMAT plans for multiple brain metastases are used for training and testing. The model performance is evaluated based on mean absolute error (MAE) and mean absolute differences of multiple dosimetric indexes (DIs), including ( and ) for OARs, ( , , , and ) for PTVs, homogeneity index, and conformity index. The similarity between the predicted and clinically approved plan dose distribution is also evaluated.

Result: For 20 tested patients, the largest and smallest MAEs are 3.3% ± 3.6% and 1.3% ± 1.5%, respectively. The mean MAE for the 20 tested patients is 2.2% ± 0.7%. The mean absolute differences of , , , and D for PTV60, PTV52, PTV50, and PTV40 are less than 2.5%, 3.0%, 2.0%, and 3.0%, respectively. The prediction accuracy of OARs for and is within 3.2% and 1.2%, respectively. The average DSC ranges from 0.86 to 1 for all tested patients.

Conclusion: U-ResNet is viable to produce accurate dose distribution that is comparable to those of the clinically approved treatment plans. The predicted results can be used to improve current treatment planning design, plan quality, efficiency, etc.

References
1.
Iwai Y, Ozawa S, Ageishi T, Pellegrini R, Yoda K . Feasibility of single-isocenter, multi-arc non-coplanar volumetric modulated arc therapy for multiple brain tumors using a linear accelerator with a 160-leaf multileaf collimator: a phantom study. J Radiat Res. 2014; 55(5):1015-20. PMC: 4202300. DOI: 10.1093/jrr/rru042. View

2.
Wolff H, Wagner D, Christiansen H, Hess C, Vorwerk H . Single fraction radiosurgery using Rapid Arc for treatment of intracranial targets. Radiat Oncol. 2010; 5:77. PMC: 2949676. DOI: 10.1186/1748-717X-5-77. View

3.
Shibamoto Y, Sugie C, Iwata H . Radiotherapy for metastatic brain tumors. Int J Clin Oncol. 2009; 14(4):281-8. DOI: 10.1007/s10147-009-0915-2. View

4.
Gronberg M, Beadle B, Garden A, Skinner H, Gay S, Netherton T . Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans. Pract Radiat Oncol. 2023; 13(3):e282-e291. PMC: 11232032. DOI: 10.1016/j.prro.2022.12.003. View

5.
Fan J, Wang J, Chen Z, Hu C, Zhang Z, Hu W . Automatic treatment planning based on three-dimensional dose distribution predicted from deep learning technique. Med Phys. 2018; 46(1):370-381. DOI: 10.1002/mp.13271. View